Landmark Liver Fibrosis Research Published in Cell, Cloud-Clone Aids ROCK2-Targeted Drug TDI01 Development

Breakthrough Study in Cell Paves Way for ROCK2-Targeted Therapy TDI01 in Liver Fibrosis   KATY, TX / 500NewsWire / June 16, 2026 / In April 2026, a groundbreaking study—Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis—was published online in the prestigious international journal Cell. This research reveals for the first time that selective upregulation of ROCK2 in liver…

Read More

Meridian Holdings (NASDAQ: MRDN) Marks 25 Years and Highlights Global Expansion With Dejan Petković Brand Partnership

LAS VEGAS, NV / 500NewsWire / June 16, 2026 / Meridian Holdings Inc. (NASDAQ: MRDN) has announced a new brand partnership in Brazilian sport with Dejan Petković, the football legend known across Brazil simply as “Pet,” who will serve as the company’s Global Brand Ambassador. In 2001, a small team in Europe launched a gaming company called Meridianbet. Twenty-five…

Read More